2024
-
Avacopan versus a Prednisone Taper in Patients with ANCA-Associated Vasculitis Without Kidney Involvement in a Phase 3 Trial
Christian Pagnoux, MD, MSc, MPH
-
Opening Session Keynote Spotlights the Crucial Role of Allyship in Rheumatology
In an opening message to ACR Convergence 2024 attendees, Dwinita Mosby Tyler, PhD, CEO and founder of The Equity Project, LLC, shared ways individuals can advance diversity, equity, and inclusion through education and self-reflection.
-
Experts in Complement-Mediated Diseases, APS, and Cutaneous Autoimmune Conditions Will Share Insights on Immune Mechanisms of Pathogenesis
Thought leaders including Christoph Licht, MD, will discuss how immunologic principles can help clarify diagnosis and treatment in rheumatology practice.
-
Researchers to Discuss Advances in the Screening, Diagnosis, and Phenotyping of ILD in Rheumatic Diseases
Experts will discuss the latest work to overcome the challenge of having no standard way of knowing who to screen for arthritis-associated interstitial lung disease. Among them, Scott Matson, MD, will share data from molecular phenotyping of RA-ILD.
-
Physician-Scientists to Review Ongoing Efforts to Reduce Steroid Use in Treating Rheumatic Diseases
Steroids have been a mainstay in the treatment of rheumatic diseases for decades, but there are proven toxicities associated with their long-term use. John Stone, MD, MPH, and other panelists will discuss the path to a steroid-free future for patients with rheumatic disease.
-
Panel to Offer Strategies to Increase Cultural Humility in Pediatric Rheumatology
Adaobi Ugochukwu, MD, a first-year pediatric resident who was diagnosed with lupus as a child, will share her perspective on living with the disease as part of a larger discussion about challenges to access to care for pediatric rheumatology patients of diverse backgrounds.
-
Session to Provide Tools for Delivering Feedback to Teammates
Nicola Orlov, MD, MPH, will introduce the audience to feedback scripts, which are essentially a framework that people can use when giving feedback about challenging behaviors.
-
Global Summit Keynote Address Explores Potential of AI in Rheumatology
The safety of patients is of the utmost concern as artificial intelligence rapidly advances into nearly every aspect of healthcare, but there are legal and ethical measures to consider as well, explained Keymanthri Moodley, PhD, MBChB.
